ERCC1 and non-small cell lung carcinoma: In line with these findings, Yang and Xian performed a meta-analysis on clinical studies of various ERCC1 SNPs including C118T in non-small cell lung cancer and found overall reduced survival in ERCC1+ patients, as well as reduced sensitivity to platinum-based chemotherapy [35].